Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Selma Boulenouar, Ph.D.

Concepts (92)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Selma Boulenouar's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Selma Boulenouar has written about over time.
Choriocarcinoma, 1 publications between 2009 and 2009, average publication date November 2009. Endometrial Neoplasms, 1 publications between 2009 and 2009, average publication date November 2009. Human papillomavirus 16, 1 publications between 2009 and 2009, average publication date November 2009. Oncogene Proteins, Viral, 1 publications between 2009 and 2009, average publication date November 2009. Papillomavirus E7 Proteins, 1 publications between 2009 and 2009, average publication date November 2009. Repressor Proteins, 1 publications between 2009 and 2009, average publication date November 2009. Uterine Cervical Neoplasms, 1 publications between 2009 and 2009, average publication date November 2009. Uterine Neoplasms, 1 publications between 2009 and 2009, average publication date November 2009. Uterus, 2 publications between 2011 and 2011, average publication date April 2011. Toll-Like Receptor 5, 1 publications between 2013 and 2013, average publication date September 2013. Lymphocytes, 2 publications between 2015 and 2017, average publication date June 2016. Adipose Tissue, 1 publications between 2017 and 2017, average publication date February 2017. Cytotoxicity, Immunologic, 1 publications between 2017 and 2017, average publication date February 2017. Homeostasis, 1 publications between 2017 and 2017, average publication date February 2017. Macrophages, 1 publications between 2017 and 2017, average publication date February 2017. Obesity, 1 publications between 2017 and 2017, average publication date February 2017. Chemokines, C, 1 publications between 2019 and 2019, average publication date October 2019. Muromonab-CD3, 1 publications between 2019 and 2019, average publication date October 2019.

To see the data from this visualization as text, click here.
Boulenouar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (92)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.